Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

News briefs

Drug company middlemen likely to be a focus in 118th Congress

Tribune News Service

2 Medical Stocks to Keep on Your Buy List in 2023 and 1 to Remove

The medical industry is poised for growth this year, driven by expanding medical needs and increasing federal support. Moreover, the industry is expected to thrive in times of uncertainty due to steady demand. Thus, quality medical stocks McKesson Corp. (MCK) and Cardinal Health (CAH) could be ideal buys this year.…

StockNews.com

Drug company middlemen likely to be a focus in 118th Congress

WASHINGTON — Factions of the health care system and members of Congress are turning their fire on an oft-maligned part of the drug pricing system — the middlemen who negotiate discounts with drug companies on behalf of health plans.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

EU Commission 'has a responsibility to come clean' on 'Pfizergate': EU Ombudsman

Emily O'Reilly, who heads the EU Ombudsman, says she has been stonewalled by the European Commission when asking for information in relation to the "Pfizergate" affair. At the core of this controversy is an exchange of text messages between the EU Commission chief and the CEO of Pfizer in the…

France 24

The Best Healthcare Stock on Wall Street to Buy Now

Pfizer (PFE) topped Wall Street’s EPS and revenue estimates in the third quarter. Moreover, the company updated its guidance for fiscal 2022. Analysts expect the stock to rise more than 16% in the near term. Therefore, it could be wise to buy the stock now. Keep reading….

StockNews.com

'Addicted after taking it once': How meth is devastating Sudanese youth

Many Sudanese activists are becoming concerned about the spread of the highly addictive synthetic drug methamphetamine, nicknamed “ice” or “Satan”. In light of the growing issue, some have started campaigns to raise awareness and opened rehabilitation centres. They say the government is failing to do enough.

France 24

Noah Feldman: Abortion pill lawsuit won’t get a fair shake in post-Roe America

The first significant stage of post-Roe abortion litigation is underway and focuses heavily on abortion pills. GenBioPro, a pharmaceutical company that makes the drug mifepristone, has asked a federal court to declare that West Virginia’s anti-abortion law is inconsistent with the Federal Drug Administration’s determination that the pill is safe…

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Hong Kong to ban CBD, label it a 'dangerous drug'

Hong Kong will ban CBD starting Wednesday, labeling it a “dangerous drug.”

The Independent UK

FDA declines to regulate CBD; calls on Congress for fix

The Food and Drug Administration says there are too many unknowns about CBD products to regulate them as foods or supplements

The Independent UK

Asda proposes staff shake-up with 300 jobs at risk and thousands of workers facing pay cut

Over 4,000 workers could see their pay reduced due to shift changes

Manchester Evening News

Ministers ‘actively considering’ laughing gas ban

Nitrous oxide is one of the most commonly-used drugs among 16 to 24-year-olds in England and can have damaging side-effects, the Home Office said.

The Independent UK

Over 200 Asda jobs at risk and 4,100 workers face pay cut under shake-up plans

The retailer is proposing that some overnight shifts at 184 stores are moved to the daytime, putting 211 night shift manager roles at risk

Chronicle Live

Nearly 300 roles at risk as Asda announces major shake-up

A boss at Asda said the retail sector is 'evolving at pace'

Nottingham Post

Almost 300 jobs at risk at Asda and 4,100 staff face pay cut

The retailer also said it will cut hours at in-store Post Office stores and close seven pharmacies.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Dynamite News

COVID-19: India Gets Its Own Nasal Vaccine, Union Ministers Mansukh Mandaviya, Jitendra Singh Launch iNCOVACC

The vaccine has been developed by India's Bharat Biotech. It will be available to the government for ₹ 325 per dose, but it will cost ₹ 800 to private hospitals. Read further on Dynamite News:

The Independent UK

What is laughing gas and why do MPs want to ban it?

Ministers reportedly planning to prohibit sale and possession of nitrous oxide

The Canberra Times

Welcome to the new Aussies: pharmacists, astronomers and cleaners

"Study Hard. Play Hard" - PM to 9-year-old

StockNews.com

2 Pharma Stocks to Buy Now for Big Gains

The pharma industry is well-placed to benefit from the rise of chronic diseases and an aging population. Moreover, given the stable demand for medicines, the industry is relatively unaffected by macroeconomic uncertainty. Therefore, it could be wise for investors to buy fundamentally strong pharma stocks AstraZeneca (AZN) and Novartis (NVS).…

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

Noem vows charges over abortion pills

Anyone prescribing the pills, Noem said, "with the intent to induce an abortion is guilty of a felony"

The Guardian - UK

Ignore the ‘superpower’ boasts – UK pharma looks superchallenged

NHS crisis, withdrawal of tax credits and exit from EU blamed for fall in UK share of R&D market

The Independent UK

New lawsuits target state restrictions on abortion pills

Supporters of abortion rights have filed separate lawsuits challenging abortion pill restrictions in North Carolina and West Virginia

Daily Mirror

Farmer pays strangers' pharmacy bills without them knowing for 10 years

Hody Childress restored faith in humanity with his selfless actions of donating $100 (£80.82) to Geraldine Drugs, in Alabama, every month to help those struggling to cover the cost of their pharmacy bills

The Independent UK

Badenoch says menopause ‘is priority area’ after calls to ‘change tack’

Kemi Badenoch defended the Government’s rejection of recommendations by the Women and Equalities Committee on menopause and the workplace.

StockNews.com

1 Biotech Stock to Buy in January 2023 and 1 to Sell

Amid rising demand and government investments, the biotech industry is poised to witness significant growth in the foreseeable future. Given this backdrop, quality biotech stock Gilead Sciences (GILD) might be a wise addition to your portfolio this January. However, Stoke Therapeutics (STOK) could be best avoided, given its bleak fundamentals.…

Evening Standard

The natural-needle combo (with micro-botox) is the answer to fine lines

Anne McElvoy finds rejuvenation and fresh skin at two of the capital’s best facialists

1 … 58 59 60 61

People

Dipanjan BanchurSince

Sristi Suman Jayaswal

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

322 stories

Pfizer Inc

312 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.